ABNORMAL SEROTONERGIC CONTROL OF PROLACTIN AND CORTISOL SECRETION IN PATIENTS WITH SEASONAL AFFECTIVE-DISORDER

被引:23
作者
COIRO, V
VOLPI, R
MARCHESI, C
DEFERRI, A
DAVOLI, C
CAFFARRA, P
ROSSI, G
CAFFARRI, G
DAVOLIO, M
CHIODERA, P
机构
[1] CLIN PSYCHIAT VILLA MARIA LUIGIA,MONTICELLI,ITALY
[2] HOSP CREMONA,DIV INTERNAL MED,CREMONA,ITALY
[3] HOSP GUASTALLA,BIOCHEM LAB,GUASTALLA,ITALY
[4] UNIV PARMA,SCH MED,DEPT PSYCHIAT,I-43100 PARMA,ITALY
[5] UNIV PARMA,SCH MED,INST INTERNAL MED,I-43100 PARMA,ITALY
[6] UNIV PARMA,SCH MED,INST NEUROL,I-43100 PARMA,ITALY
关键词
D O I
10.1016/0306-4530(93)90032-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of the serotonergic agent d,l-fenfluramine (60 mg PO) or a placebo on serum prolactin (PRL) and cortisol levels were evaluated in seven patients (five men and two women) with seasonal affective disorders (SAD) and in eight normal controls (eight men and two women). Both groups were tested in fall/winter when patients with SAD suffered depressive symptoms and in spring/summer, when patients were euthymic. Spring/summer and fall/winter tests gave similar results. PRL and cortisol patterns were similar in all subjects after placebo, whereas both hormonal responses to d,l-fenfluramine were significantly lower in patients with SAD than in normal controls. Correlation studies between the two hormonal responses revealed that on both periods the amplitudes of PRL and cortisol increments were significantly and positively correlated in patients with SAD. These data show diminished serotonergic responsiveness in SAD regardless of the actual depressive status of the patients. They are consistent with a decrease of central serotonergic activity in SAD.
引用
收藏
页码:551 / 556
页数:6
相关论文
共 15 条
[1]   THE NEURO-ENDOCRINE RESPONSE TO FENFLURAMINE IN DEPRESSIVES AND NORMAL CONTROLS [J].
ASNIS, GM ;
EISENBERG, J ;
VANPRAAG, HM ;
LEMUS, CZ ;
FRIEDMAN, JMH ;
MILLER, AH .
BIOLOGICAL PSYCHIATRY, 1988, 24 (01) :117-120
[2]  
COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587
[3]  
DELGADO PL, 1990, ARCH GEN PSYCHIAT, V47, P411
[4]   NEURO-ENDOCRINE AND BEHAVIORAL-EFFECTS OF DIETARY TRYPTOPHAN RESTRICTION IN HEALTHY-SUBJECTS [J].
DELGADO, PL ;
CHARNEY, DS ;
PRICE, LH ;
LANDIS, H ;
HENINGER, GR .
LIFE SCIENCES, 1989, 45 (24) :2323-2332
[5]   BIOCHEMICAL PHARMACOLOGY OF THE ANORECTIC DRUG FENFLURAMINE - REVIEW [J].
GARATTINI, S ;
CACCIA, S ;
MENNINI, T ;
SAMANIN, R ;
CONSOLO, S ;
LADINSKY, H .
CURRENT MEDICAL RESEARCH AND OPINION, 1979, 6 :15-27
[6]  
HAMILTON M, 1967, BR J CLIN PSYCHOL, V278, P261
[7]   ABNORMAL PITUITARY-ADRENAL RESPONSES TO CORTICOTROPIN-RELEASING HORMONE IN PATIENTS WITH SEASONAL AFFECTIVE-DISORDER - CLINICAL AND PATHOPHYSIOLOGICAL IMPLICATIONS [J].
JOSEPHVANDERPOOL, JR ;
ROSENTHAL, NE ;
CHROUSOS, GP ;
WEHR, TA ;
SKWERER, R ;
KASPER, S ;
GOLD, PW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1382-1387
[8]   HORMONAL RESPONSES TO FENFLURAMINE IN DEPRESSED AND CONTROL SUBJECTS [J].
MITCHELL, P ;
SMYTHE, G .
JOURNAL OF AFFECTIVE DISORDERS, 1990, 19 (01) :43-51
[9]  
OKEANE V, 1991, AM J PSYCHIAT, V148, P1009
[10]  
ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72